In order to improve the quality of medicines, pharmaceutical companies will continue to increase their investment in pharmaceutical equipment

With the advent of the Industry 4.
0 era, under the joint promotion of automation, Internet of Things, and information technology, all traditional manufacturing industries are upgrading smart manufacturing, and the pharmaceutical industry is no exception
.
It is understood that in recent years, major pharmaceutical companies have significantly increased their investment in intelligent construction
.
Pharmaceutical equipment (photo source: Pharmaceutical Network) For example, since 2018, Foci has begun to introduce advanced automated production equipment, expand production scale, and vigorously promote the construction of smart factories and digital workshops
.
At present, the temperature, pressure, and time of each type of medicine in the extraction tank are set by automated procedures
.
The fully automatic and intelligent processing technology not only eliminates artificial cutting corners, but also ensures that the pills can extract enough effective ingredients
.
In addition, as far as the author knows, two other pharmaceutical companies have completed intelligent transformation in 2019.
Through the construction of digital workshops for oral liquid preparations, Chinese medicine extraction and solid preparations of Chinese medicine, a total of 100 sets of automated equipment have been installed to promote The production efficiency has increased by 39%, the product qualification rate has increased to 99.
55%, and the annual production capacity of pharmaceutical drugs has also increased to 1.
8 billion
.
In fact, a common problem in most pharmaceutical companies is that it is difficult to strictly guarantee the pharmaceutical level
.
Therefore, in order to solve this pain point, more and more companies are beginning to implement intelligent transformation and launch intelligent production lines to improve the quality of pharmaceutical production and better protect the needs of the medical consumer market
.
But it is worth noting that the investment required for the intelligent transformation of production is very huge
.
The current situation of China's pharmaceutical industry is small, scattered and low
.
As a small and medium-sized enterprise, it is often difficult to afford the huge costs and risks of transformation
.
Therefore, the industry believes that most companies can start with partial technological transformation and improvement, try from one workshop and one production line, and gradually realize the replication of the intelligent transformation plan of the workshop and even the group
.
Of course, in this context, pharmaceutical companies cannot do without the help of pharmaceutical equipment companies
.
The industry believes that the pharmaceutical equipment industry will also usher in a period of development opportunities in the context of the intelligent transformation of pharmaceutical production by pharmaceutical companies
.
In fact, according to the author's understanding, to meet the intelligent production of pharmaceutical companies in the future, there are already pharmaceutical equipment companies that can provide pharmaceutical companies with end-to-end digital solutions for pharmaceutical companies and meet the current development needs of domestic pharmaceutical companies
.
According to the company’s personnel, on the production side, the company has been able to provide pharmaceutical companies with solutions for electronic batch records (EBR), production traceability, production execution, quality control, etc.
as the core pharmaceutical manufacturing execution by providing intelligent solutions for pharmaceutical production.
The system helps pharmaceutical companies improve management and accumulate big data in various aspects such as management compliance, process precipitation, and quality improvement, and help pharmaceutical companies achieve safety assurance and sustainable development capabilities
.
In addition to the above-mentioned companies, in fact, there are domestic pharmaceutical equipment giants such as Chutian Technology, Tofflon Technology, and Canaan Technology that are working in the field of domestic pharmaceutical intelligent production
.
Among them, Chutian Technology started the construction of a new model of intelligent manufacturing as early as February 2016, and created a new model of high-end biomedical robots and equipment intelligent manufacturing through the establishment of a wholly-owned subsidiary, Chutian Intelligent Robots
.
Canaan Technology has invested 1 billion yuan to develop smart medical equipment manufacturing projects.
It is reported that all three standardized production workshops have been completed, and the rest are progressing in an orderly manner
.
It is planned to be completed by the end of 2021 and completed in 2023
.
After it is put into production, it is expected to achieve an annual output of 4,000 sets of high-end pharmaceutical equipment, and the company's output value will increase by 5 times
.
It is worth mentioning that in the next step, Canaan Technology will also make efforts in digital technology, intelligent production, digital management, networked collaboration, and personalized customization to create a two-way "factory of the future"
.
At the same time, the company will also strive to improve the capabilities of intelligence and overall line engineering design to provide users with more high-value-added services
.
On the whole, my country's pharmaceutical equipment industry is gradually embarking on a process of upgrading and transformation as the demand for smart devices by pharmaceutical companies continues to increase.
Domestic pharmaceutical equipment companies led by Teflon and Chutian Technology have steadily increased their R&D investment and improved product performance.
At the same time, the business is also accelerating in the direction of an intelligent overall solution provider
.
The industry predicts that, in this context, the competition model of China's pharmaceutical equipment industry will continue to develop, market share will gradually increase, and the industry will also usher in a business cycle in 2021
.
At the same time, with the advancement of more pharmaceutical equipment intelligent manufacturing projects, it will also help improve the overall intelligent level of China's pharmaceutical equipment, promote the intelligent transformation and upgrading of the pharmaceutical industry, and provide better guarantees for the quality and safety of pharmaceutical production
.